Early Breast Cancer Content | Docwire News

Early Breast Cancer

Advertisement

Enhertu Combo Boosts pCR in High-Risk HER2+ Early Breast Cancer: DESTINY-Breast11 Findings

Brandon TwyfordHER2 Breast Cancer | May 7, 2025

Enhertu plus THP improved pCR over standard chemo in high-risk HER2+ early breast cancer, DESTINY-Breast11 shows.

Neoadjuvant Immune Checkpoint Inhibitors More than Effective than Adjuvant in Early Breast Cancer

Rob DillardTriple-Negative Breast Cancer | March 25, 2025

New research suggests ICI therapy improves efficacy outcomes in early-stage breast cancer over adjuvant therapy.

Assessing the Breast Cancer Index in Premenopausal Women With Early-Stage HR+ Breast Cancer

Rob DillardHR Breast Cancer | March 25, 2025

The Breast Cancer Index assists in decision-making regarding adjuvant endocrine therapy for hormone receptor-positive BC.

Dan Forche, CEO of PreludeDx, on Molecular Diagnostics, Precision Medicine for Breast Cancer

Rob DillardBreast Cancer News | March 26, 2025

Dan Forche, CEO of PreludeDx, a leader in precision medicine for early-stage breast cancer, discusses DCISionRT.

Advertisement

Advertisement

Advertisement

Latest News

Receipt of Maternal Warmth Influences Adolescent Health, Mental Well-Being

June 13, 2025

Neoadjuvant Immunity: Oncolytic Virus + Chemo Shows Promise in Early TNBC

June 12, 2025

Epilepsy Prevalence Increased Years Before Frontotemporal Dementia Diagnosis

June 12, 2025